Recurrent Reversible Cerebral Vasoconstriction Syndrome and Antiphospholipid Syndrome
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Dingli D, Tan T, Kumar S, Buadi F, Dispenzieri A, Hayman S
. Stem cell transplantation in patients with autonomic neuropathy due to primary (AL) amyloidosis. Neurology. 2010; 74(11):913-8.
DOI: 10.1212/WNL.0b013e3181d55f4d.
View
2.
Boitet R, de Gaalon S, Duflos C, Marin G, Mawet J, Burcin C
. Long-Term Outcomes After Reversible Cerebral Vasoconstriction Syndrome. Stroke. 2019; 51(2):670-673.
DOI: 10.1161/STROKEAHA.119.027703.
View
3.
Chen S, Fuh J, Lirng J, Wang Y, Wang S
. Recurrence of reversible cerebral vasoconstriction syndrome: a long-term follow-up study. Neurology. 2015; 84(15):1552-8.
DOI: 10.1212/WNL.0000000000001473.
View
4.
Gupta S, Zivadinov R, Ramasamy D, Ambrus Jr J
. Reversible cerebral vasoconstriction syndrome (RCVS) in antiphospholipid antibody syndrome (APLA): the role of centrally acting vasodilators. Case series and review of literature. Clin Rheumatol. 2013; 33(12):1829-33.
DOI: 10.1007/s10067-013-2434-9.
View
5.
Ducros A
. Reversible cerebral vasoconstriction syndrome. Lancet Neurol. 2012; 11(10):906-17.
DOI: 10.1016/S1474-4422(12)70135-7.
View